Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Issues in discharge therapy after hospitalization for UA/NSTEMI
Autore:
Bernink, PJLM; Flather, M; Hochman, JS; Rogers, WJ;
Indirizzi:
Martini Hosp, Groningen, Netherlands Martini Hosp Groningen NetherlandsMartini Hosp, Groningen, Netherlands Royal Brompton Hosp, London SW3 6LY, England Royal Brompton Hosp London England SW3 6LY Hosp, London SW3 6LY, England St Lukes Roosevelt Hosp, New York, NY 10025 USA St Lukes Roosevelt Hosp New York NY USA 10025 osp, New York, NY 10025 USA Columbia Univ, New York, NY USA Columbia Univ New York NY USAColumbia Univ, New York, NY USA Univ Alabama, Med Ctr, Birmingham, AL 35294 USA Univ Alabama Birmingham AL USA 35294 a, Med Ctr, Birmingham, AL 35294 USA
Titolo Testata:
EUROPEAN HEART JOURNAL SUPPLEMENTS
fascicolo: J, volume: 3, anno: 2001,
pagine: J40 - J46
SICI:
1520-765X(200108)3:J<J40:IIDTAH>2.0.ZU;2-U
Fonte:
ISI
Lingua:
ENG
Soggetto:
ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; UNSTABLE ANGINA; TRIAL; CHOLESTEROL; MANAGEMENT; NIFEDIPINE; PREVENTION; MORTALITY;
Keywords:
unstable angina; discharge therapy; guidelines; ACE inhibitors;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
23
Recensione:
Indirizzi per estratti:
Indirizzo: Bernink, PJLM Martini Hosp, Groningen, Netherlands Martini Hosp Groningen Netherlands Groningen, Netherlands
Citazione:
P.J.L.M. Bernink et al., "Issues in discharge therapy after hospitalization for UA/NSTEMI", EUR H J SUP, 3(J), 2001, pp. J40-J46

Abstract

New treatment guidelines for the management of unstable angina and non-ST-segment elevation myocardial infarction were recently issued by the ACC/AHAand the ESC. Both sets of guidelines include recommendations for dischargetherapies, and discuss the importance of aggressive risk management, as well as the use of medications, including aspirin, beta -blockers, lipid-lowering agents, and angiotensin-converting enzyme (ACE) inhibitors. These new recommendations were the subject of workshops held in September 2000, at the 4th Annual Experts' Meeting of the International Cardiology Forum. In general, workshop participants found the new ACC/AHA and ESC guidelines to be useful and consistent with practice. However, there were conflicting views on a number of topics, such as who should be treated with lipid-modifying medications, and whether the indications for ACE inhibitors should be expanded. The discussions also identified several areas of discharge management where more definitive trial data would be helpful. Some participants felt that the incremental benefit of individual agents in multidrug regimens has not yet been clearly established, There was also concern that, as the numberof effective therapies increases, lack of patient compliance and financialconstraints may impose greater limitations oil guidelines implementation. (C) 2001 The European Society of Cardiology.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/20 alle ore 07:58:08